Navigation Links
2007 Human Research Protection Award Recipients Announced
Date:12/10/2007

BETHESDA, Md., Dec. 10 /PRNewswire-USNewswire/ -- Winners of the 2007 Award for Excellence in Human Research Protection were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.

Winners were:

-- University of Kentucky (UK), for its best practice, Online Clinical

Trials Principal Investigator Self Assessment Form. This form is

designed to educate the University's researchers on the mechanisms by

which human subjects are protected. The self-assessment provides

researchers an opportunity to improve human research protections

performance of their own accord. The result of the self-assessment also

provides useful information to the UK Office of Research Integrity

(ORI) for identifying needed education/training initiatives for

researchers, their staff, UK ORI staff, and Institutional Review Board

members.

-- Washington University, for its innovation, Internet Research Guideline.

This guideline is designed for researchers and Institutional Review

Board members. It provides information on the ethical considerations

and concerns associated with research conducted via the Internet.

"The award programs offer a way to gain positive recognition for excellence in the field of human research protection," said Dr. Goldschmidt. "This year's winners continue the high standard in best practices and innovations that have been submitted for an award since the program began."

Awards are given for demonstrated excellence in promoting the well being of people who participate in research. The Health Improvement Institute created this awards program. The Office of Human Research Protection was the founding sponsor of the awards program. Judges and Committee and Award Advisory Board members are volunteers. This year's judges were drawn from provider, research review and legal/consulting organizations.

About Health Improvement Institute:

Health Improvement Institute is a non-profit, tax exempt, 501(c)3, charitable organization dedicated to improving the quality and productivity of America's health care. The Institute's principal program objective it to provide information to enable people to make informed health care choices. The Institute has established expertise in evaluating the quality of health information on the Internet, conducts forms and workshops, and sponsors national awards programs to recognize excellence, including the Award for Excellence in Human Research Protection. For more information, visit http://www.hii.org .

The Office for Human Research Protections (OHRP) - together with the federal Food and Drug Administration - oversees programs for the protections of human subjects at more than 4,000 HHS-funded universities, hospitals, and other medical and behavioral research institutions and private research sites in the United States and abroad.

For information about the 2008 Award for Excellence in Human Research Protection, please contact the Awards Coordinator at 301-320-0971 or by email at hii@hii.org.


'/>"/>
SOURCE Health Improvement Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Embryonic Stem Cells Repair Human Heart
2. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
3. Human Papilloma Virus vaccines may decrease chances of oral cancer
4. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
5. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Toddler Study Proves Humans Outsmart Apes
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. New class of RNA molecules may be important in human cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: